OrthoPediatrics Corp. logo

OrthoPediatrics Corp. (KIDS)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
19. 21
-1.16
-5.7164%
$
522.18M Market Cap
- P/E Ratio
- Div Yield
125,902 Volume
-0.91 Eps
$ 20.38
Previous Close
Add Transaction
Day Range
19.09 20.36
Year Range
14.42 23.7
Want to track KIDS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

KIDS closed today lower at $19.21, a decrease of -5.7164% from yesterday's close, completing a monthly increase of 0.1825% or $0.04. Over the past 12 months, KIDS stock gained 8.0101%.
KIDS is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0.4678%. On average, the company has surpassed earnings expectations by 0.2793%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

KIDS Chart

People also search for

Nurix Therapeutics Inc.
$ 23.12
+0.2167%
Urogen Pharma Ltd.
$ 40.23
+0.575%
GH Research plc
$ 28.71
-1.4418%
Eventide Healthcare & Life Sciences Fund Class A Shares
$ 55.12
+1.9419%
Maze Therapeutics Inc.
$ 28.12
+3.5156%
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript

OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript

OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
OrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say

OrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 2 months ago
OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates

OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.39 per share a year ago.

Zacks | 2 months ago

OrthoPediatrics Corp. Investors

Name Quantity Cost Value Profit ($) Gain (%)
SN
Stephanie Nee HARBOR CAPITAL ADVISORS Inc.
135,985 $2.67M $2.7M $30,512.8 1.14%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
35,933 $627,673.03 $714,527.7 $86,854.67 13.84%
YA
Yinka Akinsola Blue Trust Inc.
5,000 $213,318.06 $99,425 -$113,893.06 -53.39%
Joseph Castro
Joseph Castro Nuveen LLC
163,987 $2.88M $3.25M $368,798.33 12.78%
MPM
Mark P. Mennitt CenterBook Partners LP
79,396 $1.28M $1.58M $293,996.48 22.93%

OrthoPediatrics Corp. (KIDS) FAQ

What is the stock price today?

The current price is $19.21.

On which exchange is it traded?

OrthoPediatrics Corp. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is KIDS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 522.18M.

Has OrthoPediatrics Corp. ever had a stock split?

No, there has never been a stock split.

OrthoPediatrics Corp. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
David R. Bailey CEO
NASDAQ (NMS) Exchange
68752L100 CUSIP
US Country
562 Employees
- Last Dividend
- Last Split
12 Oct 2017 IPO Date

Overview

OrthoPediatrics Corp. stands as a pioneering medical device company primarily focused on the design, development, and marketing of anatomically appropriate implants, instruments, and specialty orthopedic braces for children facing orthopedic conditions. With its inception in 2006, the company has carved a niche within the pediatric orthopedic market both in the United States and on an international scale. OrthoPediatrics Corp.’s mission revolves around catering to pediatric orthopedic surgeons and caregivers, providing them with solutions specifically tailored for the unique anatomy of children. The company is headquartered in Warsaw, Indiana, where it continues to innovate and expand its reach to improve orthopedic care for children globally.

Products and Services

  • PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti

    OrthoPediatrics Corp. offers an extensive range of products tailored for pediatric trauma and deformity correction, scoliosis procedures for the treatment of spinal deformities, and sports medicine among others. Their product line includes implants such as the PediLoc and PediPlates which are designed for precision and compatibility with children’s anatomy. The company provides solutions for various orthopedic need—ranging from fracture stabilization (cannulated screws, PediFlex nail, PediNail) to complex deformity correction (RESPONSE Spine, The Fassier-Duval Telescopic Intramedullary System) and targeted growth modulation (GIROTM Growth Modulation System). Further, specialized products like the ACL Reconstruction System and the Mitchell Ponseti for clubfoot treatment showcase their dedication to addressing a wide spectrum of pediatric orthopedic challenges.

Contact Information

Address: 2850 Frontier Drive
Phone: 574 268 6379